Mithra, a company focused on Women’s Health, and Searchlight Pharma Inc., a Canadian-specialty pharmaceutical company, entered a licensing agreement for the Canadian rights to Donesta, an investigational medicine for the treatment of menopause symptoms. Searchlight will have the exclusive sales and marketing rights for Donesta in Canada. Mithra is eligible to receive up to €17.05 million in licensing fees and regulatory and sales-related milestone payments, plus royalties on Canadian annual s...